Valuation: CEREP

Market Cap 82.22M 95.98M 76.93M 70.42M 132M 9.18B 134M 909M 354M 4.61B 360M 353M 15.26B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 71.42M 57.25M 52.4M 98.35M 6.83B 99.64M 676M 264M 3.43B 268M 262M 11.35B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2024-04-10
Director TitleAgeSince
Chairman - 2023-08-10
Director/Board Member - 2024-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+3.39%+3.50%+25.49% 51.22B
-1.07%+3.69%+479.26%+607.16% 45.38B
+1.44%+5.19%+21.06%+93.98% 41.97B
+1.47%+7.58%+35.29%+21.42% 42.15B
-0.93%-4.80%+17.39%+46.60% 31.95B
-0.60%+2.87% - - 16.73B
+1.32%+6.67%+33.29%+148.62% 17.1B
+0.03%+3.91%+5.84%+35.04% 14.76B
+1.28%+4.95%+84.98%+48.41% 13.91B
Average +0.44%+3.19%+85.08%+128.34% 30.58B
Weighted average by Cap. +0.46%+3.13%+103.29%+150.63%

Financials

2024 2025
Net sales 40.49M 47.27M 37.88M 34.68M 65.08M 4.52B 65.94M 448M 175M 2.27B 177M 174M 7.51B 41.1M 47.98M 38.46M 35.2M 66.06M 4.59B 66.94M 454M 177M 2.31B 180M 176M 7.63B
Net income 7.15M 8.35M 6.69M 6.13M 11.5M 799M 11.65M 79.09M 30.84M 401M 31.36M 30.68M 1.33B 4.78M 5.58M 4.47M 4.1M 7.69M 534M 7.79M 52.87M 20.62M 268M 20.96M 20.51M 888M
Net Debt -17.25M -20.14M -16.14M -14.78M -27.73M -1.93B -28.1M -191M -74.38M -968M -75.63M -73.98M -3.2B -21.03M -24.56M -19.68M -18.02M -33.81M -2.35B -34.26M -233M -90.68M -1.18B -92.21M -90.2M -3.9B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-